In Tokyo and Osaka, Japan, Kirin Holdings Company, Limited and Immunosens Co., Ltd. have initiated a collaboration to develop a novel “Self-Testing Service” that aims to display an individual’s immune condition. With the support of the KIRIN HEALTH INNOVATION FUND, a corporate venture capital fund established in February 2023 in partnership with Global Brain Corporation, a prominent venture capital company in Japan, Kirin Holdings has invested in Immunosens. This partnership marks a significant step in the joint development of innovative healthcare solutions.